2011
DOI: 10.1007/s00280-011-1610-3
|View full text |Cite
|
Sign up to set email alerts
|

Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy

Abstract: Our findings show that lymphopenia is an independent predictive factor for both hematological toxicity and efficacy of chemotherapy in colorectal cancer. Pre-treatment lymphocyte count may represent a simple and new predictive biomarker of chemotherapy effects in colorectal cancer patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
75
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 107 publications
(81 citation statements)
references
References 40 publications
5
75
1
Order By: Relevance
“…Although neutrophils are considered to be the first line of defense against infections, lymphocytes have been reported to play a crucial role in tumor defense by inducing cytotoxic cell death and inhibiting tumor cell proliferation and migration in the tumor microenvironment [28]. In addition, the prognostic value of lymphopenia has been demonstrated in nonhematopoietic malignancies, including pancreatic cancer, esophageal cancer, colorectal cancer, and renal cell carcinoma [29-32]. In fact, the present study demonstrated that DCC patients with low lymphocyte count, high NLR, high PLR, and low LMR tended to have worse prognosis, indicating a direct influence of lymphopenia on tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…Although neutrophils are considered to be the first line of defense against infections, lymphocytes have been reported to play a crucial role in tumor defense by inducing cytotoxic cell death and inhibiting tumor cell proliferation and migration in the tumor microenvironment [28]. In addition, the prognostic value of lymphopenia has been demonstrated in nonhematopoietic malignancies, including pancreatic cancer, esophageal cancer, colorectal cancer, and renal cell carcinoma [29-32]. In fact, the present study demonstrated that DCC patients with low lymphocyte count, high NLR, high PLR, and low LMR tended to have worse prognosis, indicating a direct influence of lymphopenia on tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…The median preoperative lymphocyte count was 1,690/mm 3 (range, 432-3,891), and 1,000 mm 3 was set as the cut-off value, in accordance with previous studies (15). Following the lymphocyte count, 171 patients were placed into the high-lymphocyte group and 18 patients into the low-lymphocyte group.…”
Section: Survival Analysis According To the Lymphocyte/monocyte Countmentioning
confidence: 99%
“…Previous studies have demonstrated a correlation between lymphopenia and poor prognosis of patients with various types of cancer (15,19). Lymphocytes induce cytotoxic cell death and produce cytokines that inhibit cancer cell proliferation and metastatic activity (4,20,21).…”
Section: Univariate Analysis Multivariate Analysis ------------------mentioning
confidence: 99%
See 1 more Smart Citation
“…16,17 More generally, T cell lymphopenia has been shown to be a grave prognostic indicator in multiple types of cancers. [18][19][20][21][22][23] Recently, digital PCR platforms have been developed that offer advantages over real time qPCR including the capability to obtain absolute quantification without external references and to be highly robust to variations in PCR efficiency, thus improving assay precision. [25][26][27] Digital PCR is based on limiting dilution of a sample into a large number of separate PCR reactions.…”
Section: Introductionmentioning
confidence: 99%